14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 08, 2024 Buy 200 000 Mack Gene Employee Stock Option (right to buy)
Apr 05, 2024 Buy 0 Mack Gene
Mar 28, 2024 Buy 30 000 Riley Jeffrey Scott Common Stock
Mar 26, 2024 Sell 18 750 Alder Matthias Restricted Stock Units
Mar 26, 2024 Buy 637 Alder Matthias Common Stock
Mar 26, 2024 Buy 825 Alder Matthias Common Stock
Mar 26, 2024 Buy 18 750 Alder Matthias Common Stock
Mar 26, 2024 Sell 6 085 Alder Matthias Common Stock
Mar 26, 2024 Sell 825 Alder Matthias Restricted Stock Units
Mar 26, 2024 Sell 637 Alder Matthias Restricted Stock Units
Mar 21, 2024 Buy 50 000 Fuggetta Gianluca Employee Stock Option (right to buy)
Mar 21, 2024 Buy 370 000 Alder Matthias Employee Stock Option (right to buy)
Dec 21, 2023 Sell 206 Alder Matthias Common Stock
Dec 20, 2023 Sell 637 Alder Matthias Restricted Stock Units
Dec 20, 2023 Buy 637 Alder Matthias Common Stock
Dec 07, 2023 Sell 1 820 Alder Matthias Common Stock
Oct 01, 2023 Sell 825 Alder Matthias Restricted Stock Units
Oct 01, 2023 Buy 825 Alder Matthias Common Stock
Sep 20, 2023 Buy 54 900 Richman Eric I Common Stock
Sep 20, 2023 Sell 54 900 Richman Eric I Restricted Stock Units
Sep 20, 2023 Sell 2 550 Alder Matthias Restricted Stock Units
Sep 20, 2023 Buy 2 550 Alder Matthias Common Stock
Jul 01, 2023 Sell 3 300 Alder Matthias Restricted Stock Units
Jul 01, 2023 Buy 3 300 Alder Matthias Common Stock
Jun 23, 2023 Buy 10 500 Islam Khalid Stock Option (right to buy)
Jun 23, 2023 Buy 10 500 Riley Jeffrey Scott Stock Option (right to buy)
Jun 23, 2023 Buy 10 500 Goldstein Dov A Md Stock Option (right to buy)
Jun 23, 2023 Buy 10 500 Melincoff Gwen A Stock Option (right to buy)
Jun 23, 2023 Buy 10 500 Nicaise Claude Stock Option (right to buy)
Jun 23, 2023 Buy 10 500 Hasler Hans Peter Stock Option (right to buy)
Apr 10, 2023 Buy 100 000 Ballantyne Charles Evan Employee Stock Option (right to buy)
Apr 10, 2023 Buy 50 000 Ballantyne Charles Evan Restricted Stock Units
Apr 10, 2023 Buy 0 Ballantyne Charles Evan
Mar 23, 2023 Buy 50 000 Calabrese Salvatore Employee Stock Option (right to buy)
Mar 23, 2023 Buy 25 000 Calabrese Salvatore Restricted Stock Units
Mar 23, 2023 Buy 15 000 Fuggetta Gianluca Employee Stock Option (right to buy)
Mar 23, 2023 Buy 150 000 Alder Matthias Employee Stock Option (right to buy)
Mar 23, 2023 Buy 75 000 Alder Matthias Restricted Stock Units
Dec 12, 2022 Buy 10 000 Fuggetta Gianluca Employee Stock Option (right to buy)
Sep 20, 2022 Buy 329 400 Richman Eric I Employee Stock Option (right to buy)
Sep 20, 2022 Buy 54 900 Richman Eric I Restricted Stock Units
Sep 20, 2022 Buy 10 500 Islam Khalid Stock Option (right to buy)
Sep 20, 2022 Buy 10 500 Melincoff Gwen A Stock Option (right to buy)
Sep 20, 2022 Buy 10 500 Nicaise Claude Stock Option (right to buy)
Jul 15, 2022 Buy 9 900 Calabrese Salvatore Restricted Stock Units
Jul 15, 2022 Buy 79 200 Alder Matthias Employee Stock Option (right to buy)
May 25, 2022 Buy 2 482 Richman Eric I Common stock
May 19, 2022 Buy 9 256 Richman Eric I Common Stock
May 19, 2022 Buy 4 000 Richman Eric I Common stock
May 19, 2022 Buy 3 000 Calabrese Salvatore Common Stock
May 19, 2022 Buy 3 000 Calabrese Salvatore Common Stock
Dec 23, 2021 Buy 200 000 Alder Matthias Non Qualified Stock Option (right to buy)
Dec 23, 2021 Buy 0 Alder Matthias
Aug 16, 2021 Buy 4 922 Richman Eric I Common Stock
Aug 16, 2021 Buy 4 922 Richman Eric I Common Stock
Mar 17, 2021 Sell 26 424 Richman Eric I Stock Option (right to buy)
Mar 17, 2021 Buy 123 309 Bellotto Manolo Stock Option
Mar 17, 2021 Buy 83 674 Calabrese Salvatore Stock Option
Mar 17, 2021 Buy 10 000 Riley Jeffrey Scott Stock Option
Mar 17, 2021 Buy 10 000 Hasler Hans Peter Stock Option
Mar 17, 2021 Buy 10 000 Melincoff Gwen A Stock Option
Mar 17, 2021 Buy 10 000 Nicaise Claude Stock Option
Mar 17, 2021 Buy 0 Islam Khalid Common Stock
Mar 17, 2021 Buy 25 000 Islam Khalid Stock Option
Mar 17, 2021 Buy 0 Richman Eric I Common Stock
Mar 17, 2021 Buy 10 000 Goldstein Dov A Md Stock Option
INSIDER POWER
84.476
Last 66 transactions
Buy: 2 288 889 | Sell: 116 959 (Shares)

Based on the 66 latest insides trades, we have calculated the insider power to be positive at a ratio of 84.476.

In total, the insiders bought 2 288 889 and sold 116 959 GANX shares in the last 66 trades.

Click to get the best stock tips daily for free!

About Gain Therapeutics, Inc.

Gain Therapeutics. Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites, restore protein folding, and treat disease. It is developing s... GANX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT